Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
82.429,72
-4,32%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Intellia Therapeutics Inc (NTLA) Intellia Therapeutics Inc (NTLA) Notizie

Intellia Therapeutics Inc

NTLA
10,26
0,36 (3,64%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202511:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
04/3/202522:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202522:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202522:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202522:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202522:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202522:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
03/3/202511:45PRNUSNTLA LAWSUIT ALERT: The Gross Law Firm Notifies Intellia..
28/2/202522:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202522:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202513:45EDGAR2Form 8-K - Current report
27/2/202513:30GLOBEIntellia Therapeutics Announces Fourth Quarter and Full-Year..
27/2/202511:45PRNUSThe Gross Law Firm Reminds Intellia Investors of the Pending..
24/2/202511:45PRNUSIntellia Therapeutics, Inc. Sued for Securities Law..
21/2/202522:06EDGAR2Form 8-K - Current report
20/2/202513:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
20/2/202511:45PRNUSThe Gross Law Firm Notifies Shareholders of Intellia..
13/2/202511:45PRNUSThe Gross Law Firm Notifies Shareholders of Intellia..
04/2/202522:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
31/1/202522:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202523:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/1/202513:30GLOBEIntellia Therapeutics Announces First Patient Dosed in the..
10/1/202513:30EDGAR2Form 8-K - Current report
09/1/202522:00GLOBEIntellia Therapeutics Announces Anticipated 2025 Milestones..
07/1/202523:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202513:30GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
03/12/202422:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
25/11/202413:30GLOBEIntellia Therapeutics Announces FDA Regenerative Medicine..
18/11/202413:00EDGAR2Form 8-K - Current report
16/11/202416:16GLOBEIntellia Announces First Clinical Evidence from Ongoing..
07/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:45EDGAR2Form 8-K - Current report
07/11/202413:30GLOBEIntellia Therapeutics Announces Third Quarter 2024 Financial..
05/11/202422:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
31/10/202412:30GLOBEIntellia Therapeutics Announces Two Upcoming Investor..
25/10/202422:59EDGAR2Form 8-K - Current report
24/10/202414:01GLOBEIntellia Presents Positive Results from the Phase 2 Study of..
10/10/202413:30GLOBEIntellia Therapeutics Announces New Date for Upcoming..
07/10/202413:30GLOBEIntellia Therapeutics Announces Initiation of HAELO Phase 3..
04/10/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202422:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
01/10/202413:30GLOBEIntellia Therapeutics to Present New Clinical Data from the..
12/9/202413:30GLOBEIntellia Therapeutics to Present Data from the Phase 2 Study..
03/9/202422:30GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
Apertura: 9,89 Min: 9,69 Max: 10,68
Chiusura: 9,90

La tua Cronologia

NASDAQ
NTLA
Intellia Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci